Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Impact Biomedical Inc. (IBO) had Return on Tangible Equity of 234.32% for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-24.71M |
|
-- |
|
-- |
|
$28.75M |
|
$-28.75M |
|
$4.02M |
|
$-24.74M |
|
$-24.74M |
|
$-24.77M |
|
$-24.77M |
|
$-24.77M |
|
$-24.77M |
|
$-28.75M |
|
$-2.54M |
|
10.76M |
|
10.76M |
|
$-2.30 |
|
$-2.30 |
|
| Balance Sheet Financials | |
$2.45M |
|
$0.02M |
|
$17.84M |
|
$20.29M |
|
$9.79M |
|
-- |
|
$3.27M |
|
$13.05M |
|
$7.18M |
|
$-10.57M |
|
$7.24M |
|
11.50M |
|
| Cash Flow Statement Financials | |
$-3.92M |
|
$0.00M |
|
$5.92M |
|
$0.00M |
|
$2.00M |
|
$2.00M |
|
$0.02M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.25 |
|
-- |
|
-- |
|
-- |
|
1.23 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-3.92M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-345.13% |
|
|
Return on Tangible Equity |
234.32% |
-122.08% |
|
-342.27% |
|
$0.63 |
|
$-0.36 |
|
$-0.36 |
|